Abstract
Kaposi's sarcoma (KS) developed in a patient with human T-cell leukemia virus type I (HTLV-I)-associated adult T-cell leukemia who was treated with a short-term course of monoclonal antibody immunotherapy. The presentation was transient and temporally related to the underlying clinical course. The association of KS in an HTLV-I infected, but not human immunodeficiency virus (HIV)-infected, individual should alert investigators to the occurrence of KS in retroviral-associated diseases other than acquired immunodeficiency disease syndrome. Recognition of the similarities and differences between HTLV-I and HIV infections may provide insights concerning the angiopathogenesis of KS. © 199O by The American Society of Hematology.
Cite
CITATION STYLE
Greenberg, S. J., Jaffe, E. S., Ehrlich, G. D., Korman, N. J., Poiesz, B. J., & Waldmann, T. A. (1990). Kaposi’s sarcoma in human T-cell leukemia virus type I-associated adult T-cell leukemia. Blood, 76(5), 971–976. https://doi.org/10.1182/blood.v76.5.971.bloodjournal765971
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.